Sylke
PrivateLast Round
Series A
Mar 1, 2025
Est. Valuation
$160.03M
Total Funding Raised
$15.53M
Company Overview
Sylke is a surgical devices company that has developed SYLKE™, a dressing made of pure hypoallergenic silk fibroin designed to enhance healing across surgical wounds.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials, D2C Brands, E-commerce
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sylke Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Sylke Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 1, 2025 | ||||
| Seed | Aug 1, 2024 |
Sylke Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Vaark Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 24, 2026
Grew 48% QoQ, from 25 to 37 employees.
- Jan 24, 2026
Grew 25% QoQ, from 24 to 30 employees.
Sylke Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sylke's valuation, stock price, and market status.